Neuphoria Therapeutics Inc. (NEUP)
NASDAQ · Healthcare
Neuphoria Therapeutics Inc. Operating Income 2025–2025
Neuphoria Therapeutics Inc. annual/quarterly operating income history and growth rate from 2025 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Neuphoria Therapeutics Inc. operating income for the quarter ending March 31, 2025 was 12.0 M.
- Neuphoria Therapeutics Inc. annual operating income for 2025 was -1.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neuphoria Therapeutics Inc. Operating Income — FAQ
Neuphoria Therapeutics Inc. (NEUP) operating income over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Neuphoria Therapeutics Inc.'s operating income?
Neuphoria Therapeutics Inc. (NEUP) reported operating income of -$1M for fiscal 2025.
Where can I see NEUP's operating income history?
The chart and table above show Neuphoria Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.